Weight Loss

Obesity-related conditions are among the leading causes of preventable premature death in the United States. Adults with obesity have a higher risk of developing heart disease, breathing problems like asthma and sleep apnea, type 2 diabetes, osteoarthritis, and some types of cancer, among other life-threatening conditions. 

Diseases Associated with Obesity

• Anxiety
• Depression
• Dyslipidemia
• Gallbladder disease
• Gastrointestinal reflux disease (GERD)
• Glucose intolerance, insulin resistance, and diabetes
• Gout
• Heart disease
• Heart failure
• Hypertension (HTN)
• Increased risk of certain cancers
• Non-alcoholic fatty liver disease
• Obstructive sleep apnea
• Osteoarthritis
• Stroke (CVA)

 Weight loss is associated with decreased blood pressure, improved insulin sensitivity, increased high-density lipoprotein levels, and decreased triglycerides. Loss of excessive body weight will reduce strain on the joints and improve osteoarthritis symptoms. Weight loss can uplift spirits, improve mood, reduce depression/anxiety, and reduce the incidence of GERD and gallbladder disease. Weight loss improves the quality of life and should increase life expectancy (Perreault & Bessesen, 2022 & CDC, 2021b). 

 Medications can treat obesity when lifestyle changes alone do not provide the necessary weight loss. Prescription weight-loss drugs are meant for those with a BMI greater than 30 or above 27 with obesity-related conditions, such as HTN, type 2 diabetes, dyslipidemia, or sleep apnea (Singh & Singh, 2020). 

Semaglutide is the first drug treatment to be FDA approved since 2014.

Semaglutide is administered subcutaneously once per week, and the dosage is slowly increased to reach a target dose. It works by slowing down how quickly food leaves your stomach, allowing you to not feel hunger as often. 

Please reach out to us with your questions, our healthcare provider s would be happy to answer them. 

The first weight loss consultation is completely free of cost.